Article thumbnail

Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case report

By Patrick R Benusiglio, Thomas A McKee, Xavier Montet, Jean-Marc Dumonceau, Laurence Favet, Anne-Claude George and Pierre-Yves Dietrich
Topics: Case Report
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3076251
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). A: Extramedullary relapse of multiple myeloma presenting as hematemesis and melena. Nat Clin Pract Oncol
  2. (1999). Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer
  3. (2004). Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome. Bone Marrow Transplant
  4. (2004). Gastaut JA: Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center.
  5. (2010). Greipp PR, Eastern Cooperative Oncology Group: Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. Lancet Oncol
  6. (2007). Multiple Myeloma (009) Study Investigators: Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.
  7. (2008). Multiple myeloma presenting with high-output heart failure and improving with anti-angiogenesis therapy: two case reports and a review of the literature. J Med Case Reports
  8. (2008). RS: Multiple myeloma presenting with a colonic obstruction and bony lesions: a clinical dilemma.
  9. (2008). SA: Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma.
  10. (2010). Zojer N: Renal recovery with lenalidomide in a patient with bortezomib-resistant multiple myeloma. Nat Rev Clin Oncol